Bank of New York Mellon’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-156,680
| Closed | -$1.62M | – | 4639 |
|
|
2022
Q2 | $1.62M | Sell |
156,680
-8,952
| -5% | -$66.6K | ﹤0.01% | 2948 |
|
|
2022
Q1 | $1.46M | Buy |
165,632
+6,750
| +4% | +$51.2K | ﹤0.01% | 3097 |
|
|
2021
Q4 | $1.1M | Sell |
158,882
-4,764
| -3% | -$69.9K | ﹤0.01% | 3330 |
|
|
2021
Q3 | $2.03M | Buy |
163,646
+12,723
| +8% | +$183K | ﹤0.01% | 2963 |
|
|
2021
Q2 | $2.75M | Sell |
150,923
-32,637
| -18% | -$649K | ﹤0.01% | 2802 |
|
|
2021
Q1 | $3.83M | Sell |
183,560
-6,966
| -4% | -$147K | ﹤0.01% | 2570 |
|
|
2020
Q4 | $3.4M | Sell |
190,526
-4,431
| -2% | -$66.5K | ﹤0.01% | 2538 |
|
|
2020
Q3 | $2.21M | Sell |
194,957
-6,479
| -3% | -$80.1K | ﹤0.01% | 2610 |
|
|
2020
Q2 | $2.75M | Buy |
201,436
+662
| +0.3% | +$9.12K | ﹤0.01% | 2501 |
|
|
2020
Q1 | $2.61M | Buy |
200,774
+2,704
| +1% | +$48.2K | ﹤0.01% | 2416 |
|
|
2019
Q4 | $3.99M | Sell |
198,070
-4,723
| -2% | -$115K | ﹤0.01% | 2443 |
|
|
2019
Q3 | $5.22M | Sell |
202,793
-2,802
| -1% | -$68.7K | ﹤0.01% | 2259 |
|
|
2019
Q2 | $5.01M | Buy |
205,595
+30,376
| +17% | +$664K | ﹤0.01% | 2332 |
|
|
2019
Q1 | $3.49M | Buy |
175,219
+284
| +0.2% | +$5.18K | ﹤0.01% | 2506 |
|
|
2018
Q4 | $2.88M | Sell |
174,935
-440,292
| -72% | -$7.41M | ﹤0.01% | 2559 |
|
|
2018
Q3 | $11M | Sell |
615,227
-80
| -0% | -$1.81K | ﹤0.01% | 1966 |
|
|
2018
Q2 | $18.1M | Buy |
615,307
+106,545
| +21% | +$3.37M | ﹤0.01% | 1663 |
|
|
2018
Q1 | $18.3M | Sell |
508,762
-8,546
| -2% | -$309K | 0.01% | 1620 |
|
|
2017
Q4 | $16.4M | Sell |
517,308
-16,401
| -3% | -$515K | ﹤0.01% | 1703 |
|
|
2017
Q3 | $20.6M | Buy |
533,709
+3,844
| +0.7% | +$151K | 0.01% | 1540 |
|
|
2017
Q2 | $24M | Buy |
529,865
+85,816
| +19% | +$3.28M | 0.01% | 1436 |
|
|
2017
Q1 | $17.2M | Buy |
444,049
+179,471
| +68% | +$7.53M | ﹤0.01% | 1638 |
|
|
2016
Q4 | $10.1M | Sell |
264,578
-12,278
| -4% | -$584K | ﹤0.01% | 1955 |
|
|
2016
Q3 | $15M | Sell |
276,856
-61,342
| -18% | -$3.12M | ﹤0.01% | 1633 |
|
|
2016
Q2 | $12.4M | Buy |
338,198
+185,192
| +121% | +$6.54M | ﹤0.01% | 1731 |
|
|
2016
Q1 | $4.81M | Sell |
153,006
-14,516
| -9% | -$502K | ﹤0.01% | 2198 |
|
|
2015
Q4 | $10.3M | Buy |
167,522
+11,624
| +7% | +$734K | ﹤0.01% | 1827 |
|
|
2015
Q3 | $10.8M | Buy |
155,898
+23,234
| +18% | +$1.61M | ﹤0.01% | 1825 |
|
|
2015
Q2 | $8.98M | Buy |
132,664
+72,214
| +119% | +$3.36M | ﹤0.01% | 2021 |
|
|
2015
Q1 | $2.49M | Buy |
60,450
+13,248
| +28% | +$595K | ﹤0.01% | 2707 |
|
|
2014
Q4 | $1.84M | Buy |
47,202
+30,548
| +183% | +$724K | ﹤0.01% | 2927 |
|
|
2014
Q3 | $349K | Buy |
+16,654
| New | +$225K | ﹤0.01% | 3747 |
|
Other funds holding RDUS
Bank of New York Mellon's RDUS Position: Q3 2022 in Review
Bank of New York Mellon sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 156,680 shares — an estimated $1.62M sold.
Bank of New York Mellon first reported a position in RDUS in Q3 2014 and held it in 32 quarters. The position peaked at $24M in Q2 2017. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Bank of New York Mellon reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Bank of New York Mellon sold 156,680 Radius Health, Inc. shares in Q3 2022, an estimated $1.62M.
- Bank of New York Mellon first reported a position in Radius Health, Inc. in Q3 2014 and held it in 32 quarters.
- Bank of New York Mellon's Radius Health, Inc. position peaked at $24M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.